← Back to Clinical Trials
Recruiting NCT07229365

NCT07229365 Children's Viewing Behavior

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07229365
Status Recruiting
Phase
Sponsor SightGlass Vision, Inc.
Condition Myopia
Study Type INTERVENTIONAL
Enrollment 20 participants
Start Date 2025-12-22
Primary Completion 2026-12-30

Eligibility & Interventions

Sex All sexes
Min Age 7 Years
Max Age 14 Years
Study Type INTERVENTIONAL
Interventions
Novel spectacle lens designSpectacle lenses

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 20 participants in total. It began in 2025-12-22 with a primary completion date of 2026-12-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this study is to investigate the area of the spectacle lens in which a subject is viewing through regardless of task being performed.

Eligibility Criteria

Inclusion Criteria: A person is eligible for inclusion in the study if he/she: * Is 7-14 years of age, inclusive * Requires spherical spectacle lenses within the power range available for the study lenses * Parent/guardian has read and understood the informed consent form, and the child has provided age-appropriate assent * Is willing and able to follow instructions and maintain the appointment schedule * Is correctable to a visual acuity of 20/40 or better (in each eye) with their habitual vision correction or 20/20 best corrected * Has had a self-reported oculo-visual examination in the last two years * Spectacle cylinder of ≤ -0.75DC in both eyes Exclusion Criteria: A person will be excluded from the study if he/she: * Is unable to complete the necessary study activities * Has any systemic disease affecting ocular health * Is using any systemic or topical medications (including pharmaceutical myopia control therapy) that will affect ocular health * Is aphakic

Contact & Investigator

Central Contact

Jennifer Hill

✉ jhill@sightglassvision.com

📞 6783614877

Frequently Asked Questions

Who can join the NCT07229365 clinical trial?

This trial is open to participants of all sexes, aged 7 Years or older, up to 14 Years, studying Myopia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07229365 currently recruiting?

Yes, NCT07229365 is actively recruiting participants. Contact the research team at jhill@sightglassvision.com for enrollment information.

Where is the NCT07229365 trial being conducted?

This trial is being conducted at Bloomington, United States.

Who is sponsoring the NCT07229365 clinical trial?

NCT07229365 is sponsored by SightGlass Vision, Inc.. The trial plans to enroll 20 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology